CTBO (Cantabio Pharmaceuticals) Common Stock: $0.10 Mil (As of Dec. 2018)


What is Cantabio Pharmaceuticals Common Stock?

Cantabio Pharmaceuticals CTBO Common Stock is $0.10 Mil as of Dec. 2018.

Cantabio Pharmaceuticals's quarterly common stock increased from Jun. 2018 ($0.05 Mil) to Sep. 2018 ($0.08 Mil) and increased from Sep. 2018 ($0.08 Mil) to Dec. 2018 ($0.10 Mil).

Cantabio Pharmaceuticals's annual common stock stayed the same from Mar. 2016 ($0.03 Mil) to Mar. 2017 ($0.03 Mil) but then increased from Mar. 2017 ($0.03 Mil) to Mar. 2018 ($0.05 Mil).

Cantabio Pharmaceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Cantabio Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Common Stock Chart

Cantabio Pharmaceuticals Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Common Stock
Get a 7-Day Free Trial 0.01 0.02 0.03 0.03 0.05

Cantabio Pharmaceuticals Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.05 0.05 0.08 0.10

Cantabio Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.10 Mil mean?
Cantabio Pharmaceuticals (CTBO) has a Common Stock of $0.10 Mil as of Dec. 2018. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Cantabio Pharmaceuticals and its competitors.
Is Cantabio Pharmaceuticals' Common Stock too high?
Cantabio Pharmaceuticals' current Common Stock is $0.10 Mil.
How does Cantabio Pharmaceuticals' Common Stock compare to TNTY and ETNI?
Cantabio Pharmaceuticals' Common Stock of $0.10 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Cantabio Pharmaceuticals and its competitors. Cantabio Pharmaceuticals's current Common Stock is $0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantabio Pharmaceuticals stock overvalued right now?
Cantabio Pharmaceuticals (CTBO) has a current Common Stock of $0.10 Mil. The current Common Stock is $0.10 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Cantabio Pharmaceuticals (CTBO), the current Common Stock is $0.10 Mil as of Dec. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantabio Pharmaceuticals Business Description

Address 1250 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.